A Pooled Analysis of Subcutaneous Omacetaxine Mepesuccinate for CML in Blast Crisis


A Pooled Analysis of Subcutaneous Omacetaxine Mepesuccinate for CML in Blast Crisis
Slides from a presentation at ASH 2012 and transcribed comments from recent interviews with Hagop M Kantarjian, MD (2/20/13) and Moshe Talpaz, MD (2/20/13)

Khoury HJ et al. Blast phase chronic myeloid leukemia: A pooled analysis of subcutaneous omacetaxine mepesuccinate in treatment-resistant patients. Proc ASH 2012;Abstract 3753.

Dr Kantarjian is Chairman and Professor of the Leukemia Department at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Dr Talpaz is Alexander J Trotman Professor of Leukemia Research, Associate Director of Translational Research at UM Comprehensive Cancer Center, Associate Chief of the Division of Hematology/Oncology and Director of Hematologic Malignancies at the University of Michigan Medical Center in Ann Arbor, Michigan.